Search
Skip to Search Results- 19Psychometrics
- 9Personality tests
- 8Psychological tests
- 5Health services research
- 3Education
- 3Research validity
- 27Graduate and Postdoctoral Studies (GPS), Faculty of
- 27Graduate and Postdoctoral Studies (GPS), Faculty of/Theses and Dissertations
- 3Toolkit for Grant Success
- 3Toolkit for Grant Success/Successful Grants (Toolkit for Grant Success)
- 2Canadian Health Services and Policy Research Alliance (CHSPRA)
- 2Canadian Health Services and Policy Research Alliance (CHSPRA)/Impact Assessment Working Group (CHSPRA)
-
Evaluating the Psychometric Properties of the 18-month "Ages and Stages Questionnaires" using a Canadian Sample: Making Inferences about Decision Consistency from Item and Subscale-Level Data
DownloadFall 2014
Developmental screening tools, such as "Ages and Stages Questionnaires" (ASQ) are an important addition to the pediatric care to identify developmental delays at critical age periods. ASQ questionnaires have demonstrated good psychometric properties in the US context; however sample-dependent...
-
2011-11-28
SSHRC Awarded IDG 2012: The proposed research addresses the consistency and accuracy of classification results produced by a cognitive diagnostic assessment. The objectives of the proposed research are to (1) evaluate the strengths and limitations of our two new statistical indexes in applied...
-
Reflections on the Cost of "Low-Cost" Whole Genome Sequencing: Framing the Health Policy Debate
Download2014-10-24
Miller, Fiona A., Hogarth, Stuart, Evans, Jim, McCabe, Christopher, Pullman, Daryl, Joly, Yann, Szego, Michael J., Bubela, Tania, Fishman, Jennifer, Sankar, Pamela, Cook-Deegan, Robert, Biesecker, Barbara, Ravitsky, Vardit, Borry, Pascal, K. Cho, Mildred, Ungar, Wendy, J., Ossorio, Pilar, Kato, Kazuto, Wilson, Brenda, McGuire, Amy, Soo-Jin Lee, Sandra, Caulfield, Timothy, Rothenberg, Karen, Rousseau, Francois, Etchegary, Holly, Carroll, June C.
The cost of whole genome sequencing is dropping rapidly. There has been a great deal of enthusiasm about the potential for this technological advance to transform clinical care. Given the interest and significant investment in genomics, this seems an ideal time to consider what the evidence tells...